Company intelligence / Profile preview

Kunasan

Colorado, United Stateskunasan.com ↗

Ownership: Private
Development stage: Other

Overview

Kunasan develops patented neuromodulation and digital health devices using ALFS and AI/ML to address sleep disorders, pain management, relaxation, emotional trauma relief, and pet calming. The company has a sponsored research agreement with Pennsylvania State University and recently appointed Roger Billica MD as Chief Medical Officer. Clinical results are not publicly detailed.

Therapeutic areas: PsychiatryNeurology
Modalities: DeviceDigital health deviceNeuromodulation deviceAI/ML-enabled medical deviceWearable technology
Industry: Therapeutic Medical Devices

Partnerships

Sponsored research agreement with Pennsylvania State University (#231161)

Beyond the preview

Go deeper on Kunasan.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kunasan.

Explore the full profile